Amanote Research

Amanote Research

    RegisterSign In

Discover open access scientific publications

Search, annotate, share and cite publications


Publications by David Hong

Targeting Hypoxia-Inducible Factor-1α (HIF-1α) in Combination With Antiangiogenic Therapy: A Phase I Trial of Bortezomib Plus Bevacizumab

Oncotarget
Oncology
2014English

Outcomes of Phase I Clinical Trials for Patients With Advanced Pancreatic Cancer: Update of the MD Anderson Cancer Center Experience

Oncotarget
Oncology
2017English

Outcome Analysis of Phase I Trial Patients With Metastatic KRAS and/or TP53 Mutant Non-Small Cell Lung Cancer

Oncotarget
Oncology
2018English

Phase I Studies of Vorinostat With Ixazomib or Pazopanib Imply a Role of Antiangiogenesis-Based Therapy for TP53 Mutant Malignancies

Scientific Reports
Multidisciplinary
2020English

Phase I Clinical Trial of Hepatic Arterial Infusion of Paclitaxel in Patients With Advanced Cancer and Dominant Liver Involvement

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2010English

Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined With Interferon Alpha for Patients With Solid Tumors

Journal of Cancer
Oncology
2011English
  • ‹
  • 1
  • 2

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy